Senior Director: Market Access-Europe

• Jun 2021 - Present

Nick has spent more than 27 years in the Pharmaceutical Industry, predominantly in a Market Access leadership capacity at country, regional and global levels. Nick's experience includes, Global market access capability development and cross portfolio new product planning (UK/Ireland & Nordics) with responsibility for price, reimbursement and access strategies across Phase II products and beyond. Nick has also sat in role as European market access launch leader focusing on Value Story development, pricing, launch strategy and implementation. Show less

Career Break

• Jan 2021 - May 2021

Market Access Capability Lead (International Business Unit)

• Apr 2019 - Dec 2020

Responsibility for the development and implementation of Payer Strategy capabilities in key OUS Regions.Lead the implementation of market access training curriculum with regional capability leads.Coordination of Global Market Access Excellence Awards Process

Senior Pricing, Reimbursement & Access Lead-New Product Planning

• Mar 2016 - Mar 2019

Lead on UK Hub market access input for all early phase assets ensuring cross-functional feedback into global trial design and HTA early advice and advisory boards.Manage external HTA Horizon Scanning relationship with NICE/SMC/NCPE.UK Hub Market Access Capability Lead

Pricing, Reimbursement & Access Lead: CV & Men's Health (Europe/Canada)

• Apr 2014 - Mar 2016

Portfolio Regional Market Access Leadership supporting phase 3 "go to market" planning whilst ensuring continuing commercial success of "in-market" products across priority EU affiliates/Canada.Working with Global Pricing, Reimbursement & Access teams to ensure major affiliate input into the consolidated regional strategic market access recommendations.Current role requires deep understanding of the regional external payer environment to design, develop and implement consistent payer strategies.(ie Landscape analysis including HTA environment/stakeholder mapping/coordination of regional payer insight though market research and advisory boards) Show less

Senior Pricing Reimbursement & Access Manager

• Feb 2011 - Apr 2014

Cross portfolio Market Access leadership ensuring access targets are delivered within an account management framework. Responsibility for NHS market access strategy across the biomedicines portfolio, analysing the payer environment and integrating the payer voice into business planning.Development of Core Value Messages, materials and appropriate partnership programmes across the portfolio. Market access lead for all phase 3 biomedicines development brands Responsible for development, coordination/coaching and delivery of the above strategies across Bio Medicines Business Unit through market access team and cross functional business functions. Show less

Manager: UK Health Outcomes Liaison Team

• Feb 2008 - Feb 2011

Leadership/Responsibility for set up of National field based market access team providing focused regional Pricing,Access and Health Outcomes support to sales/KAM divisions.

Senior Sales Manager

• Apr 2005 - Feb 2008

National Sales Responsibility for Specialist Hospital Portfolio (Osteoporosis and Endocrine) (8 reports)

Manager: Specialist Care KAM Team (Northern UK)

• Nov 2002 - Apr 2005

Disease Areas- Critical Care / Oncology/ OsteoporosisLed KAM team (6 reports) responsible for portfolio Market Access across Specialist Care business unit

District Sales Manager

• Nov 2000 - Nov 2002

NHS Liaison Manager

• Jan 1999 - Nov 2000

Senior Medical Representative

• Sep 1996 - Jan 1999